콘텐츠로 건너뛰기
Merck

1.16883

Fractogel® EMD DEAE (M)

weak anion exchanger, suspension in 20% ethanol and 150 mM NaCl (40-90 µm)

동의어(들):

Fractogel® EMD DEAE (M)

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

UNSPSC Code:
41115711
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의


Quality Segment

ligand

diethylaminoethyl

product line

Fractogel®

form

resin

parameter

170 cm/hr flow rate, 8 bar max. pressure

matrix active group

methacrylate

mean particle size

40-90 μm

capacity

100 mg binding capacity (BSA/mg of resin)

transition temp

flash point 35 °C (calculated)

density

1.430 g/cm3

bulk density

1000 kg/m3

application(s)

gene therapy
mAb
vaccine development

separation technique

weak anion exchange

storage temp.

2-30°C

General description

Weak anion exchange Fractogel® resin featuring the tentacle technology, for purification of acidic and neutral proteins and peptides from multiple sources, pDNA purification, DNA, RNA, and endotoxin removal, large viruses purification, vaccine purification, blood fractionation, and more

Features and Benefits

Fractogel® EMD DEAE (M) enables:

  • Excellent binding to large viruses and plasmid DNA
  • Homogenous binding with high selectivity and purity
  • Lower elution volumes for the highest purity levels
  • Compatibility with 2.5 % (v/v) aqueous benzyl alcohol containing 150 mM NaCl storage solution


Due to the titration behavior, the ion exchange capacity can be used from pH 2 to pH 9.5. The separation of proteins is based on reversible electrostatic interactions between the negatively charged regions of the proteins′ surface and the support. Proteins are retained efficiently on Fractogel® EMD DEAE when the pH of the buffer is about 1 unit above their isoelectric points (pl).

The strength of the binding depends on the following:
  • the buffer system
  • pH value of the buffer which determines the surface charge of the protein
  • the degree of the ionization of the functional groups of the exchanger
  • the concentration of the counter ions
  • the charge density on the support (protein binding capacity)

Packaging

  • 1.16883.0100: Fractogel® EMD DEAE (M) Resin 100ml
  • 1.16883.0010: Fractogel® EMD DEAE (M) Resin 10ml
  • 1.16883.0500: Fractogel® EMD DEAE (M) Resin 500ml
  • 1.16883.5000: Fractogel® EMD DEAE (M) Resin 5L

Plastic bottle

Analysis Note

Appearance: Milky turbid suspension,free from impurities (foreign particles)
Microscopic evaluation: Uniform spherical particles,no agglomerates,no fines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1 bar
Particle size (d10): 37 - 45 µm
Particle size (d50): 48 - 60 µm
Particle size (d90): 63 - 77 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Protein binding capacity (bovine serum albumin): 80 - 120 mg/ml
Functional test (b:a): ≤ 0.25
Functional test: Separation of conalbumin and human serum albumin

Legal Information

FRACTOGEL is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under Fractogel® EMD DEAE (M)


pictograms

Flame

signalword

Warning

hcodes

Hazard Classifications

Flam. Liq. 3

저장 등급

3 - Flammable liquids

wgk

WGK 3

flash_point_f

95.0 °F

flash_point_c

35 °C



Emprove® 프로그램을 사용하여 GMP 준수 유지

Emprove® Dossiers로 자격을 가속화하고, 규정 준수를 유지하며, 시간을 절약하세요.

Dossiers 다운로드

주: EmproveSuite.com으로 이동하게 됩니다. 귀하의 사용자 이름과 비밀번호는 시그마알드리치닷컴과는 별개이며 다를 수 있습니다.

무료로 등록하고 몇 분 안에 Emprove® Dossiers에 액세스하세요. 구독 플랜을 업그레이드하여 Emprove® Suite에서 고급 및 맞춤형 콘텐츠를 잠금 해제하세요.

원하는 정보를 찾지 못하셨나요? Emprove® 프로그램 도움말 페이지 방문하기.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문


문서

See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.

Free eBook outlines plasmid DNA manufacturing process and downstream purification challenges for various applications.

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

모든 기사 보기

관련 콘텐츠

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.

This page summarizes key considerations related to regulatory expectations for biomanufacturing including chemicals and polymeric materials. For chemicals, topics include nitrosamines and elemental impurities, and for polymeric materials such as filters and single-use assemblies, the focus is qualification and extractable and leachable testing.

관련 콘텐츠 모두 보기




국제 무역 품목 번호

SKUGTIN
1.16883.050004022536168715
1.16883.500004022536168722
1.16883.010004022536741949
1.16883.001004022536168708